Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Current Assets (2018 - 2025)

Historic Current Assets for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $154.1 million.

  • Verastem's Current Assets rose 2767.57% to $154.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $154.1 million, marking a year-over-year increase of 2767.57%. This contributed to the annual value of $95.0 million for FY2024, which is N/A changed from last year.
  • Per Verastem's latest filing, its Current Assets stood at $154.1 million for Q3 2025, which was up 2767.57% from $174.3 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Current Assets registered a high of $190.0 million during Q2 2023, and its lowest value of $92.9 million during Q4 2022.
  • For the 5-year period, Verastem's Current Assets averaged around $124.4 million, with its median value being $116.2 million (2021).
  • In the last 5 years, Verastem's Current Assets skyrocketed by 9408.74% in 2023 and then plummeted by 4754.45% in 2024.
  • Over the past 5 years, Verastem's Current Assets (Quarter) stood at $105.7 million in 2021, then dropped by 12.17% to $92.9 million in 2022, then soared by 87.88% to $174.5 million in 2023, then tumbled by 45.58% to $95.0 million in 2024, then surged by 62.23% to $154.1 million in 2025.
  • Its Current Assets stands at $154.1 million for Q3 2025, versus $174.3 million for Q2 2025 and $124.7 million for Q1 2025.